This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Forma Therapeutics, Inc., Novo Nordisk Healthcare Ag. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: The Innovative Contributions of Madhu Mondal
Introduction
Madhu Mondal is an accomplished inventor based in Winchester, MA, known for his significant contributions to the field of biotechnology. With a total of two patents to his name, he has made strides in developing methods and compositions that address critical health issues.
Latest Patents
His latest patents include groundbreaking work on activating pyruvate kinase R. The compound (S)-1-(5-((2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan-1-one, or a pharmaceutically acceptable salt thereof, is designed to increase the affinity of hemoglobin for oxygen. Additionally, he has developed methods and compositions for the treatment of hemoglobinopathies, including certain pharmaceutical compositions for activating PKR. Another notable patent involves inhibiting mutant isocitrate dehydrogenase 1 (mIDH1), which is useful in the treatment of mIDH1 cancers, including acute myeloid leukemia (AML) and mIDH1-positive solid tumors such as glioma.
Career Highlights
Throughout his career, Madhu Mondal has
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile